MilCAM: Light Therapy in the Treatment of Leg Pain
Study Details
Study Description
Brief Summary
The purpose of this study is to apply Anodyne therapy to active duty soldiers, who have shin splints, to evaluate healing time and effectiveness.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Tibial stress reactions and fractures are often difficult to treat, and therefore, many soldiers proceed to a medical disability/discharge. It is felt that with the use of the MIRE technology, active duty soldiers with tibial stress reactions and fractures will heal more quickly and completely. All soldiers will have a documented bone scintigraph as evidence for tibial stress reaction or fracture prior to enrollment. In addition, pain-pressure goniometric measures and time to complete the Balke protocol will also be used to assess healing with the MIRE technology.
Comparison: Soldiers with Active MIRE technology, compared to soldiers with Placebo MIRE technology.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Infrared Light Therapy Intervention: The use of infrared light therapy for the treatment of tibial fracture. The treatment was assigned three times a week for four weeks. |
Device: Monochromatic Near-Infrared Light Energy (MIRE)
Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.
|
Placebo Comparator: Standard of Care Standard of care was characterized by the use of standard medical treatment to include medication. |
Device: Monochromatic Near-Infrared Light Energy (MIRE)
Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.
|
Outcome Measures
Primary Outcome Measures
- Visual Analog Scale [4 weeks]
Numeric scale based on pain level (1-10). The higher the numeric value, the higher the pain level, as perceived by the participant.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Active duty soldier
-
Exertional leg pain of greater than 3 months duration
-
Documented bone scintigraphic evidence for tibial stress reaction or fracture
Exclusion Criteria:
-
Known leg Pathology other than stress reaction or fracture
-
Service members known to be leaving area within next 6 months
-
Pregnant females
-
High risk cardiopulmonary patients
-
Patients with assisted walking devices
-
Patients with two or more cardiac risk factors
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | William Beaumont Army Medical Center | El Paso | Texas | United States | 79920 |
Sponsors and Collaborators
- Samueli Institute for Information Biology
- William Beaumont Army Medical Center
Investigators
- Principal Investigator: LTC Richard P Petri, MD, Department of the Army
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- WBAMC #05/13
- CIRO #2005705
Study Results
Participant Flow
Recruitment Details | The recruitment took place between 2006-2007 at a military treatment facility. |
---|---|
Pre-assignment Detail | Some participants were excluded due to deployment, military training that required them to leave the post. |
Arm/Group Title | Infrared Light Therapy | Standard of Care |
---|---|---|
Arm/Group Description | Intervention: The use of infrared light therapy for the treatment of tibial fracture. The treatment was assigned three times a week for four weeks. | Standard of care was characterized by the use of standard medical treatment to include medication. |
Period Title: Overall Study | ||
STARTED | 16 | 14 |
COMPLETED | 16 | 14 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Experimental | Control | Total |
---|---|---|---|
Arm/Group Description | The experimental group received the monochromatic light infrared energy treatment (MIRE). | The control group followed the standard of care for the treatment of shin splints, usually physical therapy and medication. | Total of all reporting groups |
Overall Participants | 16 | 14 | 30 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
16
100%
|
14
100%
|
30
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Sex: Female, Male (Count of Participants) | |||
Female |
1
6.3%
|
0
0%
|
1
3.3%
|
Male |
15
93.8%
|
14
100%
|
29
96.7%
|
Region of Enrollment (participants) [Number] | |||
United States |
16
100%
|
14
100%
|
30
100%
|
Outcome Measures
Title | Visual Analog Scale |
---|---|
Description | Numeric scale based on pain level (1-10). The higher the numeric value, the higher the pain level, as perceived by the participant. |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Infrared Light Therapy | Standard of Care |
---|---|---|
Arm/Group Description | Intervention: The use of infrared light therapy for the treatment of tibial fracture. The treatment was assigned three times a week for four weeks. | Standard of care was characterized by the use of standard medical treatment to include medication. |
Measure Participants | 0 | 0 |
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Experimental | Control | ||
Arm/Group Description | The experimental group received the monochromatic light infrared red energy treatment (MIRE). | The control group followed the standard of care for the treatment of shin splints, usually physical therapy and medication. | ||
All Cause Mortality |
||||
Experimental | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Experimental | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/14 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Experimental | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/14 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | COL Richard Petri, Chief Integrative Pain Management |
---|---|
Organization | William Beaumont Army Medical Center |
Phone | 915-742-3245 |
richard.petri@amedd.army.mil |
- WBAMC #05/13
- CIRO #2005705